台股 » 個股 » 醣聯 » 籌碼相關 » 券商分點績效

醣聯

(4168)
可現股當沖
  • 股價
    24.90
  • 漲跌
    ▲0.10
  • 漲幅
    +0.40%
  • 成交量
    57
  • 產業
    上櫃 生技醫療類股▲0.51%
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
醣聯 (4168)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/11/21     後一日»

券商獲利排行 - 2024/11/21

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  1.01%10144024.724.7024.9
  0.30%0.30.3004424.824.824.924.9
  0.28%0.30.20.104324.924.824.924.9
  0.20%0.200.255024.924.9024.9
  0.40%0.200.222024.824.8024.9
  0.27%0.200.233024.824.8024.9
  0.20%0.200.244024.924.9024.9
  0.05%0.20.3-0.1-831124.924.824.924.9
  0.20%0.100.1-2022502524.9
  0.20%0.100.1-10224.924.92524.9
  0.40%0.100.111024.824.8024.9
  0.40%0.100.111024.824.8024.9
  0.40%0.100.111024.824.8024.9
  0.20%0.100.1-1012502524.9
  0.20%00011024.924.9024.9
  0.20%00011024.924.9024.9
  0.00%000-20224.9024.924.9
   0000002525024.9
   0000002525024.9
   0000002525024.9
   0000002525024.9
   0000002502524.9
   0000002525024.9
   0000002525024.9
   0000002525024.9
   0000002525024.9
   00000024.9024.924.9
   0000002525024.9
   0000002525024.9
   0000002525024.9
   0000002525024.9
  0.00%00001124.924.924.924.9
   0000002525024.9
   0000002502524.9
   00000024.9024.924.9
   0000002525024.9
  0.00%00011024.924.9024.9
  0.00%00033024.924.9024.9
  -0.20%000-10124.9024.924.9
  -0.20%000-10124.9024.924.9
  -0.20%000-10124.9024.924.9
  -0.20%000-10124.9024.924.9
  -0.20%000-10124.9024.924.9
  -0.13%-0.10-0.1-30324.9024.924.9
  -0.40%-0.10-0.1-10124.8024.824.9
  -0.40%-0.10-0.1-10124.8024.824.9
  -0.40%-0.10-0.1-10124.8024.824.9
  -0.40%-0.10-0.1-10124.8024.824.9
  -0.20%-0.10-0.12202525024.9
  -0.07%-0.1-0.1036324.924.924.924.9

券商虧損排行 - 2024/11/21

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.01%-10-1-40424.7024.724.9
  -0.20%-0.50-0.5101002525024.9
  -0.20%-0.20-0.2-50524.9024.924.9
  -0.81%-0.20-0.2-10124.7024.724.9
  -0.40%-0.20-0.2-20224.8024.824.9
  -0.40%-0.20-0.2-20224.8024.824.9
  -0.07%-0.1-0.1036324.924.924.924.9
  -0.20%-0.10-0.12202525024.9
  -0.40%-0.10-0.1-10124.8024.824.9
  -0.40%-0.10-0.1-10124.8024.824.9
  -0.40%-0.10-0.1-10124.8024.824.9
  -0.40%-0.10-0.1-10124.8024.824.9
  -0.13%-0.10-0.1-30324.9024.924.9
  -0.20%000-10124.9024.924.9
  -0.20%000-10124.9024.924.9
  -0.20%000-10124.9024.924.9
  -0.20%000-10124.9024.924.9
  -0.20%000-10124.9024.924.9
  0.00%00033024.924.9024.9
  0.00%00011024.924.9024.9
   0000002525024.9
   0000002525024.9
   0000002525024.9
   0000002525024.9
   0000002525024.9
   0000002502524.9
   0000002525024.9
   0000002525024.9
   0000002525024.9
   0000002525024.9
   0000002525024.9
   0000002525024.9
   00000024.9024.924.9
   0000002525024.9
   0000002502524.9
   0000002525024.9
  0.00%00001124.924.924.924.9
   00000024.9024.924.9
   0000002525024.9
  0.00%000-20224.9024.924.9
  0.20%00011024.924.9024.9
  0.20%00011024.924.9024.9
  0.20%0.100.1-1012502524.9
  0.40%0.100.111024.824.8024.9
  0.40%0.100.111024.824.8024.9
  0.40%0.100.111024.824.8024.9
  0.20%0.100.1-2022502524.9
  0.20%0.100.1-10224.924.92524.9
  0.05%0.20.3-0.1-831124.924.824.924.9
  0.20%0.200.244024.924.9024.9
醣聯完成生物相似藥一期試驗 Q4啟動三期臨床Anue鉅亨-2024/08/19
醣聯智財版圖再擴大 抗癌新藥獲多國專利Anue鉅亨-2024/06/24
醣聯 相關文章
醣聯 相關影音